Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Detection and clinical significance of dense breast tissue

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.02.18
Views: 701

Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia

Prof Ingman speaks with ecancer about the impact of dense breast tissue on breast cancer detection and development.

She outlines the InforMD project, which seeks to inform management and guidelines of dense breast tissue, as well as empower patients in conversations with their doctors.

Prof Ingman encourages awareness of screening options to determine breast density, noting the additional costs and risk of false positives, and highlights the lack of national guidelines on the subject. 

Read more about the InforMD project here.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence